| Overview |
| bs-9984R-FITC |
| C22orf25 Polyclonal Antibody, FITC Conjugated |
| WB, IF |
| Human, Mouse, Rat |
| Specifications |
| FITC |
| Rabbit |
| KLH conjugated synthetic peptide derived from human C22orf25 |
| Polyclonal |
| #REF! |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 128989 |
| Q6ICL3 |
| Uncharacterized protein C22orf25; chromosome 22 open reading frame 25; DKFZp 761 P 1121; Hypothetical protein LOC128989; TNG2_HUMAN; TANGO2; Transport and Golgi organization protein 2 homolog. |
| Chromosome 22 contains over 500 genes and about 49 million bases. Being the second smallest human chromosome, 22 contains a surprising variety of interesting genes. Phelan-McDermid syndrome, Neurofibromatosis type 2 and autism are associated with chromosome 22. A schizophrenia susceptibility locus has been identified on chromosome 22 and studies show that 22q11 deletion symptoms include a high incidence of schizophrenia. Translocations between chromosomes 9 and 22 may lead to the formation of the Philadelphia Chromosome and the subsequent production of the novel fusion protein, BCR-Abl, a potent cell proliferation activator found in several types of leukemia. The C22orf25 gene product has been provisionally designated C22orf25 pending further characterization. |
| Application Dilution |
| WB |
1:300-5000 |
| IF |
IHC-P1:50-200 |
Powered by Bioz
© 2025